Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has conclu ...

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...

The first line of pharmacological treatment for schizophrenia is antipsychotic medication. However, antipsychotic medications are ineffective in more than 30% of people with the disorder. This is ...

In jails and prisons, drugs are still available, effective treatment is rare, and overdoses occur. People can also cycle in and out of jail, ending up back on the street without meaningful care or ...

mixing or altering drug ingredients − have prospered amid shortages of the class of weight-loss medications, called GLP-1 (glucagon-like peptide-1) receptor agonists. Hims & Hers, which ...

Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, United States ...

False Belief 1: Drug experimentation is normal for teens and shouldn’t alarm parents. Drug use and experimentation among teens often is ignored by many—even parents, who then may be unaware ...

covered in the analyst's report "Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven -Market Drug Forecast and Market Analysis", published in April 2024.